Announcements Trials
Browse Landscape

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Blood Specimen Collection 87Surveys and Questionnaires 86Surgical Procedures, Operative 45Drug Therapy 33Radiotherapy 28Biopsy 26Neoadjuvant Therapy 24Amplified Fragment Length Polymorphism Analysis 24Immunohistochemistry 22Gene Expression Profiling 21Bevacizumab 19Magnetic Resonance Spectroscopy 17Immunotherapy 17Data Collection 17Ultrasonography 16Positron Emission Tomography Computed Tomography 16Liquid Biopsy 16pembrolizumab 15Observation 15Nivolumab 15Watchful Waiting 14Radiosurgery 14Microarray Analysis 14Magnetic Resonance Imaging 14Interviews as Topic 14Immune Checkpoint Inhibitors 14Colonoscopy 13Capecitabine 13Polymerase Chain Reaction 12Paclitaxel 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Observational × BCG Vaccine × Clear all
NCT05332353 2022-04-18

Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients

Mansoura University

Unknown
100 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡